Several randomized controlled trials are underway to confirm the safety and efficacy of early vs late initiation of direct oral anticoagulants in ischemic stroke associated with atrial fibrillation.
Atrial fibrillation is associated with a faster global cognitive decline and an increased risk for dementia in older people.
Investigators observed a significant association between atrial fibrillation and increasing oxygen desaturation index.
A retrospective cohort study was conducted to assess the effect of surgical left atrial appendage occlusion on risk for readmission due to thromboembolism in older patients.
Investigators assessed the presence of cerebral microbleeds as a biomarker for identifying patients at increased risk for intracranial hemorrhage as a result of anticoagulation for atrial fibrillation.
Investigators retrospectively reviewed treatment patterns and long-term outcomes in 30,626 patients with ischemic stroke and AF who had these data recorded in 4 Danish healthcare registries.
Investigators conducted 2 retrospective cohort studies to determine whether patients with resolved AF were at an increased risk for stroke or TIA and all-cause mortality compared with matched controls with unresolved AF.
For patients with CKD and atrial fibrillation, anticoagulants are linked with an increased risk of ischemic stroke.
Blacks are at an increased risk of developing ischemic stroke, before or after atrial fibrillation diagnosis.
CHA2DS2-VASc score assessment is more predictive of ischemic stroke in patients with atrial fibrillation than the baseline score.
Although there was little difference in efficacy, apixaban did have a better safety profile than warfarin, dabigatran, and rivaroxaban.
Updated antithrombotic therapy recommendations for patients with atrial fibrillation have been provided.
Ablation is associated with reduced risk of recurrent stroke for patients with artrial fibrillation.
Risk scores help identify high-risk patients who may benefit from intervention.
Mechanisms including silent cerebral infarct, microemboli, microbleedings, and cerebral hypoperfusion may be responsible for the link between atrial fibrillation and cognitive decline.
The investigators noted that rivaroxaban was associated with significantly reduced length of hospital stay compared with warfarin.
Dual therapy was associated with a significantly higher bleeding risk.
Delays in anticoagulation treatment resulted in increased risk for dementia.
Neglecting abnormalities in ECG readings could result in serious acute cardiac events in patients presenting with stroke.
Patients taking apixaban showed significantly less intracranial hemorrhage (0.33% per year) vs patients taking warfarin (0.80% per year), no matter the type and location.
More than 80% of ischemic stroke patients weren't getting adequate anticoagulation therapy.
Clinicians should closely monitor patients with atrial fibrillation, especially if they are female and of increasing age.
Early intervention in patients with heart failure or atrial fibrillation may help delay or prevent the onset of mild dementia.
It is not clear if identifying atrial fibrillation in an effort to prevent stroke would be an effective preventive strategy.
The increased risk of stroke was only observed among patients with diabetes controlled by insulin.
At 1 year, no difference in complications was observed between the 2 age groups.
Twelve months after AFib ablation, risk of recurrent stroke or AFib is low.
Only 46% of patients with indications received OACs at discharge from the hospital.
32.1% believed that heart attack is a major risk factor of AF, which is incorrect.
Reduced REM sleep was correlated with a 23% increased risk of atrial fibrillation, while insomnia was associated with a 29% increased risk.
Neurology Advisor Articles
- Case Study Report: Herbal Supplement Kratom Associated With Neonatal Abstinence Syndrome
- Seizure Monitoring Smartwatch Cleared for Use in Children
- Ocrelizumab Reduces Upper Extremity Disability Progression Risk in PPMS
- Can Early Initiation of Direct Oral Anticoagulants Prevent Recurrent AFib-Related Stroke?
- Online Family Problem-Solving Program May Improve Behavioral Outcomes in Older Children With TBI
- Very Early Mobilization After Stroke Does Not Improve Survival Over Usual Care
- Alemtuzumab Linked to Clinical and MRI Disease Remission in Multiple Sclerosis
- Cognitive Decline Worsens With Memantine, ChEIs in Patients With Alzheimer's
- Cervical Dysfunction Needs Clarification to Identify Link With Headache
- Levodopa Inhalation Powder Approved for Parkinson Disease
- Risk for Conversion of MS Varies With Different Therapies
- Breakdown of Blood-Brain Barrier May Drive Dementia
- FDA: Food Inspections to Resume Despite Ongoing Funding Lapse
- First Generic Version of Sabril Tablets Gets FDA Approval
- Supine Positioning After Greater Occipital Nerve Block May Improve Outcomes